Showing 1 - 20 results of 21 for search 'Preetesh Jain', query time: 0.06s
Refine Results
-
1
Overview of recent developments in chronic lymphocytic leukemia by Preetesh Jain, Kanti R Rai
Published 2012-01-01
Article -
2
Zanubrutinib in lymphoproliferative disorders: a comprehensive review by Javier Muñoz, Yucai Wang, Preetesh Jain, Michael Wang
Published 2022-05-01
Article -
3
Advances in the assessment of minimal residual disease in mantle cell lymphoma by Dayoung Jung, Preetesh Jain, Yixin Yao, Michael Wang
Published 2020-09-01
Article -
4
-
5
<i>MYC</i> rearrangement but not extra <i>MYC</i> copies is an independent prognostic factor in patients with mantle cell lymphoma by Lifu Wang, Guilin Tang, L. Jeffrey Medeiros, Jie Xu, Wenting Huang, C. Cameron Yin, Michael Wang, Preetesh Jain, Pei Lin, Shaoying Li
Published 2020-04-01
Article -
6
Management of a patient with mantle cell lymphoma who developed severe neurotoxicity after chimeric antigen receptor T-cell therapy in ZUMA-2 by Michael Wang, Preetesh Jain, T Linda Chi, Sheree E Chen, Amy Heimberger, Shiao-Pei Weathers, Lianqing Zheng, Arati V Rao, John M Rossi
Published 2020-10-01
Article -
7
Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations by Yuxuan Che, Yang Liu, Yixin Yao, Holly A. Hill, Yijing Li, Qingsong Cai, Fangfang Yan, Preetesh Jain, Wei Wang, Lixin Rui, Michael Wang
Published 2023-02-01
Article -
8
Assessment at 6 months may be warranted for patients with chronic myeloid leukemia with no major cytogenetic response at 3 months by Aziz Nazha, Hagop Kantarjian, Preetesh Jain, Carlos Romo, Elias Jabbour, Alfonso Quintas-Cardama, Raja Luthra, Lynne Abruzzo, Gautam Borthakur, Farhad Ravandi, Sherry Pierce, Susan O’Brien, Jorge Cortes
Published 2013-11-01
Article -
9
Immune-depleted tumor microenvironment is associated with poor outcomes and BTK inhibitor resistance in mantle cell lymphoma by Preetesh Jain, Krystle Nomie, Nikita Kotlov, VitaIy Segodin, Holly Hill, Chi Young Ok, Ahmed Fetooh, Rashmi Kanagal-Shamanna, Francisco Vega, Alexander Bagaev, Nathan Fowler, Christopher R. Flowers, Michael Wang
Published 2023-10-01
Article -
10
Low-dose radiation (4 Gy) with/without concurrent chemotherapy is highly effective for relapsed, refractory mantle cell lymphoma by Matthew S. Ning, Chelsea C. Pinnix, Bhavana V. Chapman, Jillian R. Gunther, Sarah A. Milgrom, Joseph D. Khoury, Preetesh Jain, Wendy Y. Chen, Onyeka N. Oriabure, Maria R. Badillo, L. Michael Wang, Bouthaina S. Dabaja
Published 2019-07-01
Article -
11
Frontline therapy with high-dose imatinib versus second generation tyrosine kinase inhibitor in patients with chronic-phase chronic myeloid leukemia – a propensity score analysis by Koji Sasaki, Hagop Kantarjian, Elias Jabbour, Farhad Ravandi, Koichi Takahashi, Marina Konopleva, Gautam Borthakur, Guillermo Garcia-Manero, William Wierda, Naval Daver, Preetesh Jain, Toshihisa Satta, Sherry Pierce, May Beth Rios, Jorge E. Cortes
Published 2016-08-01
Article -
12
Potentiation of apoptosis in drug-resistant mantle cell lymphoma cells by MCL-1 inhibitor involves downregulation of inhibitor of apoptosis proteins by Yijing Li, Heng-Huan Lee, Vivian Changying Jiang, Yuxuan Che, Joseph McIntosh, Alexa Jordan, Jovanny Vargas, Tianci Zhang, Fangfang Yan, Margaret Elizabeth Simmons, Wei Wang, Lei Nie, Yixin Yao, Preetesh Jain, Michael Wang, Yang Liu
Published 2023-11-01
Article -
13
Th17 and non-Th17 interleukin-17-expressing cells in chronic lymphocytic leukemia: delineation, distribution, and clinical relevance by Preetesh Jain, Mohammad Javdan, Franziska K. Feger, Pui Yan Chiu, Cristina Sison, Rajendra N. Damle, Tawfiqul A. Bhuiya, Filiz Sen, Lynne V. Abruzzo, Jan A. Burger, Andreas Rosenwald, Steven L. Allen, Jonathan E. Kolitz, Kanti R. Rai, Nicholas Chiorazzi, Barbara Sherry
Published 2012-04-01
Article -
14
TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma by Vivian Changying Jiang, Dapeng Hao, Preetesh Jain, Yijing Li, Qingsong Cai, Yixin Yao, Lei Nie, Yang Liu, Jingling Jin, Wei Wang, Heng-Huan Lee, Yuxuan Che, Enyu Dai, Guangchun Han, Ruiping Wang, Kunal Rai, Andrew Futreal, Christopher Flowers, Linghua Wang, Michael Wang
Published 2022-09-01
Article -
15
Humoral Immunity and Antibody Responses against Diphtheria, Tetanus, and Pneumococcus after Immune Effector Cell Therapies: A Prospective Study by Georgios Angelidakis, Roy F. Chemaly, Pranoti V. Sahasrabhojane, Oscar Morado-Aramburo, Ying Jiang, Micah M. Bhatti, Elizabeth Shpall, Chitra Hosing, Preetesh Jain, Kris Michael Mahadeo, Fareed Khawaja, Peter Elhajj, Jennifer A. Wargo, Robert R. Jenq, Nadim J. Ajami, Partow Kebriaei, Ella J. Ariza-Heredia
Published 2024-09-01
Article -
16
Final results and overall survival data from a phase II study of acalabrutinib monotherapy in patients with relapsed/refractory mantle cell lymphoma, including those with poor prog... by Steven Le Gouill, Monika Długosz-Danecka, Simon Rule, Pier Luigi Zinzani, Andre Goy, Stephen D. Smith, Jeanette K. Doorduijn, Carlos Panizo, Bijal D. Shah, Andrew J. Davies, Richard Eek, Eric Jacobsen, Arnon P. Kater, Tadeusz Robak, Preetesh Jain, Roser Calvo, Lin Tao, Michael Wang
Published 2023-07-01
Article -
17
Outcomes and toxicities in patients with diffuse-large B cell lymphoma involving the gastrointestinal tract and digestive organs by Gohar S. Manzar, Elaine E. Cha, Kelsey L. Corrigan, Alison K. Yoder, Benjamin R. Schrank, Lewis F. Nasr, Dai Chihara, Luis Malpica Castillo, Ranjit Nair, Preetesh Jain, Sattva S. Neelapu, Maria A. Rodriguez, Paolo Strati, Loretta J. Nastoupil, Jillian R. Gunther, Bouthaina S. Dabaja, Chelsea C. Pinnix, Susan Y. Wu, Penny Q. Fang
Published 2024-09-01
Article -
18
Safety of Concurrent Radiation Therapy With Brentuximab Vedotin in the Treatment of Lymphoma by Susan Y. Wu, MD, Penny Q. Fang, MD, MBA, Ethan B. Wang, BA, Sairah Ahmed, MD, Madeleine Duvic, MD, Preetesh Jain, MD, Luis E. Malpica Castillo, MD, Ranjit Nair, MD, Raphael E. Steiner, MD, Paolo Strati, MD, Auris O. Huen, MD, PharmD, Swaminathan P. Iyer, MD, Chelsea C. Pinnix, MD, PhD, Bouthaina S. Dabaja, MD, Jillian R. Gunther, MD, PhD
Published 2023-11-01
Article -
19
Ultra–Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the Lung by Susan Y. Wu, MD, Penny Q. Fang, MD, MBA, Ahmed Fetooh, MBBS, Gohar S. Manzar, MD, PhD, Kelsey L. Corrigan, MD, MPH, Benjamin R. Schrank, MD, PhD, Lewis Nasr, MD, MS, Dai Chihara, MD, PhD, Luis E. Malpica Castillo, MD, Ranjit Nair, MD, Raphael E. Steiner, MD, Preetesh Jain, MBBS, MD, DM, PhD, Sattva S. Neelapu, MD, Paolo Strati, MD, Loretta J. Nastoupil, MD, Bouthaina S. Dabaja, MD, Chelsea C. Pinnix, MD, PhD, Jillian R. Gunther, MD, PhD
Published 2024-12-01
Article -
20
Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma by Shaojun Zhang, Vivian Changying Jiang, Guangchun Han, Dapeng Hao, Junwei Lian, Yang Liu, Qingsong Cai, Rongjia Zhang, Joseph McIntosh, Ruiping Wang, Minghao Dang, Enyu Dai, Yuanxin Wang, David Santos, Maria Badillo, Angela Leeming, Zhihong Chen, Kimberly Hartig, John Bigcal, Jia Zhou, Rashmi Kanagal-Shamanna, Chi Young Ok, Hun Lee, Raphael E. Steiner, Jianhua Zhang, Xingzhi Song, Ranjit Nair, Sairah Ahmed, Alma Rodriquez, Selvi Thirumurthi, Preetesh Jain, Nicolaus Wagner-Bartak, Holly Hill, Krystle Nomie, Christopher Flowers, Andrew Futreal, Linghua Wang, Michael Wang
Published 2021-05-01
Article